$ELRE
Yinfu Gold Corp.

2022 Q3 Form 10-Q Financial Statement

#000164033422001865 Filed on August 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $112.7K $120.4K $118.7K
YoY Change -9.19% 7.93% 2.26%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.20K $14.36K $18.64K
YoY Change -39.46% -21.27% -74.48%
% of Gross Profit
Operating Expenses $112.7K $120.4K $118.7K
YoY Change -9.2% 7.93% 2.26%
Operating Profit -$112.7K -$120.4K
YoY Change -9.2% 7.93%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $155.00 $833.00 -$170.00
YoY Change -162.0% -200.0%
Pretax Income -$112.6K -$119.6K -$118.8K
YoY Change -9.5% 7.19% 2.55%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$112.6K -$119.6K -$118.8K
YoY Change -9.5% 7.19% 2.55%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$56.73K -$301.3K -$59.91K
COMMON SHARES
Basic Shares Outstanding 1.984M shares 9.918M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.110K $1.540K $530.00
YoY Change 290.74% 258.14% 76.67%
Cash & Equivalents $2.108K $1.544K $525.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.761K $8.735K $6.840K
YoY Change 129.13% 197.31% 242.86%
LONG-TERM ASSETS
Property, Plant & Equipment $26.43K $39.81K $6.480K
YoY Change -39.89% -36.32% -91.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $26.43K $39.81K $6.481K
YoY Change -39.9% -36.32% -91.86%
TOTAL ASSETS
Total Short-Term Assets $9.761K $8.735K $6.840K
Total Long-Term Assets $26.43K $39.81K $6.481K
Total Assets $36.19K $48.55K $13.32K
YoY Change -24.97% -25.83% -83.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $204.1K $196.7K $177.4K
YoY Change 126.91% 97.12% 77.95%
Accrued Expenses $26.87K $40.27K $26.48K
YoY Change -57.42% -50.7% -73.12%
Deferred Revenue
YoY Change
Short-Term Debt $242.6K $236.0K $228.7K
YoY Change 39.96% 35.98% 33.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.596M $2.556M $2.458M
YoY Change 16.01% 19.86% 21.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.596M $2.556M $2.458M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.596M $2.556M $2.458M
YoY Change 16.01% 19.86% 21.37%
SHAREHOLDERS EQUITY
Retained Earnings -$2.634M -$2.521M -$2.401M
YoY Change 23.59% 24.54%
Common Stock $1.984K $1.984K $1.984K
YoY Change -80.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.560M -$2.508M -$2.444M
YoY Change
Total Liabilities & Shareholders Equity $36.19K $48.55K $13.32K
YoY Change -24.97% -25.83% -83.68%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$112.6K -$119.6K -$118.8K
YoY Change -9.5% 7.19% 2.55%
Depreciation, Depletion And Amortization $11.20K $14.36K $18.64K
YoY Change -39.46% -21.27% -74.48%
Cash From Operating Activities -$41.62K -$48.23K -$35.36K
YoY Change -26.26% 19.8% -78.36%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 42.21K $49.27K 35.27K
YoY Change -25.37% 22.0% -78.39%
NET CHANGE
Cash From Operating Activities -41.62K -$48.23K -35.36K
Cash From Investing Activities 0.000 $0.00 0.000
Cash From Financing Activities 42.21K $49.27K 35.27K
Net Change In Cash 590.0 $1.019K -90.00
YoY Change 391.67% 683.85% -47.06%
FREE CASH FLOW
Cash From Operating Activities -$41.62K -$48.23K -$35.36K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001438461
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1983993 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1983993 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1983993 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1983993 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1983993 shares
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
333-152242
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
YINFU GOLD CORPORATION
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8531222
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 2313
CY2022Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Dongfang Science and Technology Mansion
CY2022Q2 dei Entity Address Address Line3
EntityAddressAddressLine3
Nanshan District
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Shenzhen
CY2022Q2 dei Entity Address Country
EntityAddressCountry
CN
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
518000
CY2022Q2 dei City Area Code
CityAreaCode
755
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
8316-0998
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
CY2022Q2 dei Trading Symbol
TradingSymbol
ELRE
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1983993 shares
CY2022Q2 us-gaap Liabilities
Liabilities
2556298 usd
CY2022Q1 us-gaap Liabilities
Liabilities
2457748 usd
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1983993 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1984 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1984 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7934 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7934 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2521042 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2401469 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3374 usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52876 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2507750 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2444427 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48548 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13321 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2021Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
99336 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
103292 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
21070 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
8264 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
120406 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
111556 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-120406 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-111556 usd
CY2022Q2 us-gaap Noninterest Income
NoninterestIncome
1 usd
CY2021Q2 us-gaap Noninterest Income
NoninterestIncome
0 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
832 usd
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
833 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-119573 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-111556 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-119573 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-111556 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
56250 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12429 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-63323 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-123985 usd
CY2022Q2 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.06
CY2021Q2 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.06
CY2022Q2 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
1983993 shares
CY2021Q2 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
1983993 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1943306 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-111556 usd
CY2021Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-12429 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2067291 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2444427 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-119573 usd
CY2022Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
56250 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2507750 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-119573 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-111556 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
14363 usd
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18241 usd
CY2022Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1232 usd
CY2021Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-787 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
24101 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
105 usd
CY2022Q2 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-33109 usd
CY2021Q2 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-18241 usd
CY2022Q2 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
67218 usd
CY2022Q2 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
0 usd
CY2021Q2 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
71979 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48232 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40259 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
17567 usd
CY2021Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
31705 usd
CY2021Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
40388 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49272 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40388 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-21 usd
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1019 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
130 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
525 usd
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1544 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
430 usd
CY2022Q2 elre Recognized Rou Assets Through Lease Liabilities
RecognizedROUAssetsThroughLeaseLiabilities
-48532 usd
CY2021Q2 elre Recognized Rou Assets Through Lease Liabilities
RecognizedROUAssetsThroughLeaseLiabilities
0 usd
CY2007Q1 elre Common Stock Increase Authorized Capital Shares
CommonStockIncreaseAuthorizedCapitalShares
1000000000 shares
CY2022Q2 elre Interim Financial Informationpolicytextblock
InterimFinancialInformationpolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The unaudited financial statements have been prepared in accordance with generally accepted accounting principles (GAAP) applicable to interim financial information and the requirements of Form 10-Q and Rule 8-03 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not include all of the information and disclosure required by accounting principles generally accepted in the United States of America for complete financial statements. Interim results are not necessarily indicative of results for a full year. In the opinion of management, all adjustments considered necessary for a fair presentation of the financial position and the results of operations and cash flows for the interim periods have been included.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These financial statements should be read in conjunction with the audited financial statements as of and for the year ended March 31, 2022, as not all disclosures required by generally accepted accounting principles for annual financial statements are presented. The interim financial statements follow the same accounting policies and methods of computations as the audited financial statements as of and for the year ended March 31, 2022.</p>
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ from these good faith estimates and judgments. </p>
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
56250 usd
CY2022Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents as well as related party payables that it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposure is limited.</p>
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-111556 usd
CY2022Q2 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
1983993 shares
CY2021Q2 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
1983993 shares
CY2022Q2 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.06
CY2022Q2 us-gaap Due From Related Parties
DueFromRelatedParties
236026 usd
CY2022Q1 us-gaap Due From Related Parties
DueFromRelatedParties
228675 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2521042 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-119573 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
48232 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1983993 shares
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
5-in-1
CY2022Q2 elre Incremental Borrowing Rate
IncrementalBorrowingRate
0.0475 pure
CY2022Q2 elre Operating Lease Expenses
OperatingLeaseExpenses
14580 usd
CY2021Q2 elre Operating Lease Expenses
OperatingLeaseExpenses
19126 usd
CY2020Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
135832 usd

Files In Submission

Name View Source Status
0001640334-22-001865-index-headers.html Edgar Link pending
0001640334-22-001865-index.html Edgar Link pending
0001640334-22-001865.txt Edgar Link pending
0001640334-22-001865-xbrl.zip Edgar Link pending
elre-20220630.xsd Edgar Link pending
elre_10q.htm Edgar Link pending
elre_ex311.htm Edgar Link pending
elre_ex312.htm Edgar Link pending
elre_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
elre-20220630_pre.xml Edgar Link unprocessable
elre-20220630_lab.xml Edgar Link unprocessable
elre-20220630_def.xml Edgar Link unprocessable
elre_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
elre-20220630_cal.xml Edgar Link unprocessable